Aptamers Market Share
The Aptamers Market has witnessed substantial growth over the past decade, driven by the increasing adoption of aptamers in diagnostics and therapeutic applications. Aptamers, often referred to as “chemical antibodies,” are short single-stranded nucleic acids capable of binding to specific targets with high affinity and specificity. Unlike traditional antibodies, aptamers offer advantages such as lower immunogenicity, easier synthesis, and better stability under various conditions.
The diagnostic sector has been a key contributor to the market expansion. Aptamers are increasingly utilized in biosensors, point-of-care testing, and disease detection assays due to their rapid binding capabilities and specificity. For instance, aptamer-based biosensors provide real-time monitoring of biomolecules, which is critical in early disease detection. This ability to detect diseases at early stages has spurred demand in both developed and emerging markets.